Cargando…
Where will telemedicine go from here?
The COVID-19 pandemic accelerated the adoption of telemedicine internationally. The reproductive clinics that thrived in this tumultuous time had access to fully electronic medical records with user-friendly telehealth platforms and remote support staff for physicians. However, complete transition f...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Reproductive Medicine, Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135996/ https://www.ncbi.nlm.nih.gov/pubmed/33280718 http://dx.doi.org/10.1016/j.fertnstert.2020.10.050 |
_version_ | 1784714077888577536 |
---|---|
author | Rotker, Katherine Velez, Danielle |
author_facet | Rotker, Katherine Velez, Danielle |
author_sort | Rotker, Katherine |
collection | PubMed |
description | The COVID-19 pandemic accelerated the adoption of telemedicine internationally. The reproductive clinics that thrived in this tumultuous time had access to fully electronic medical records with user-friendly telehealth platforms and remote support staff for physicians. However, complete transition from in-person visits to telehealth uncovered many opportunities for innovation. At-home semen testing is not yet widely recognized, and patients still require an in-person visit for ultrasounds, procedures, and physical examinations. Although emergency policies and waivers have made it easier for providers to legally practice across state borders and receive payments from insurance companies, they vary from state to state and have not been cemented into law. Finally, clinical training for medical students, residents, and fellows has been affected by decreased clinical and surgical volume. However, trainees have also proven to be the most adaptable, quickly shifting to remote learning practices through social media, online surgical atlases, and wide distribution of “virtual visiting professor” lectures. As countries have eased physical distancing guidelines, patients ultimately benefit from having the option of a telehealth appointment. Although there is still much work to be done to improve telehealth, the COVID-19 pandemic has at least proven that it is a safe method of patient care and teaching. |
format | Online Article Text |
id | pubmed-9135996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society for Reproductive Medicine, Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91359962022-05-31 Where will telemedicine go from here? Rotker, Katherine Velez, Danielle Fertil Steril Views and Reviews The COVID-19 pandemic accelerated the adoption of telemedicine internationally. The reproductive clinics that thrived in this tumultuous time had access to fully electronic medical records with user-friendly telehealth platforms and remote support staff for physicians. However, complete transition from in-person visits to telehealth uncovered many opportunities for innovation. At-home semen testing is not yet widely recognized, and patients still require an in-person visit for ultrasounds, procedures, and physical examinations. Although emergency policies and waivers have made it easier for providers to legally practice across state borders and receive payments from insurance companies, they vary from state to state and have not been cemented into law. Finally, clinical training for medical students, residents, and fellows has been affected by decreased clinical and surgical volume. However, trainees have also proven to be the most adaptable, quickly shifting to remote learning practices through social media, online surgical atlases, and wide distribution of “virtual visiting professor” lectures. As countries have eased physical distancing guidelines, patients ultimately benefit from having the option of a telehealth appointment. Although there is still much work to be done to improve telehealth, the COVID-19 pandemic has at least proven that it is a safe method of patient care and teaching. American Society for Reproductive Medicine, Published by Elsevier Inc. 2020-12 2020-12-03 /pmc/articles/PMC9135996/ /pubmed/33280718 http://dx.doi.org/10.1016/j.fertnstert.2020.10.050 Text en ©2020 American Society for Reproductive Medicine, Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Views and Reviews Rotker, Katherine Velez, Danielle Where will telemedicine go from here? |
title | Where will telemedicine go from here? |
title_full | Where will telemedicine go from here? |
title_fullStr | Where will telemedicine go from here? |
title_full_unstemmed | Where will telemedicine go from here? |
title_short | Where will telemedicine go from here? |
title_sort | where will telemedicine go from here? |
topic | Views and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135996/ https://www.ncbi.nlm.nih.gov/pubmed/33280718 http://dx.doi.org/10.1016/j.fertnstert.2020.10.050 |
work_keys_str_mv | AT rotkerkatherine wherewilltelemedicinegofromhere AT velezdanielle wherewilltelemedicinegofromhere |